IL-1 inhibitor (TopoTarget)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIL-1 inhibitor (TopoTarget)
Drug Alias NameIL-1 inhibitor (Apoxis)Inflammasome
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsGoutChondrocalcinosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApoxis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApoxisTopotarget AS
Active IndicationsN/A
Inactive IndicationsGoutChondrocalcinosis

Other Information

ATC CodeN/A
Related LinksN/A